We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Science briefs.
- Abstract
This section offers news briefs on biotechnology. A licensing agreement was signed by the animal health division of Bayer HealthCare with Juvaris BioTherapeutics, which gives Bayer access in the veterinary field to the mono-immunotherapy and vaccine technology being developed by Juvaris for human health care. Upperton entered a collaboration agreement with Novozymes focusing on the commercialisation of rP-nanoTM drug delivery technology. O2 will supply Senexis with synthetic and computational chemistry services.
- Subjects
BIOTECHNOLOGY; LICENSE agreements; BAYER HealthCare AG; JUVARIS BioTherapeutics Inc.; UPPERTON Ltd.; NOVOZYMES A/S; SENEXIS Ltd.
- Publication
Chemistry & Industry, 2008, Issue 7, p11
- ISSN
0009-3068
- Publication type
Article